A Phase 2 Study of REOLYSIN in Combination With Gemcitabine for Patients With Advanced Pancreatic Adenocarcinoma.
Phase of Trial: Phase II
Latest Information Update: 06 Jul 2015
At a glance
- Drugs Pelareorep (Primary) ; Gemcitabine
- Indications Pancreatic cancer
- Focus Therapeutic Use
- Sponsors Oncolytics Biotech
- 06 Jul 2015 According to Oncolytics Biotech media release, final data has been presented at the European Society for Medical Oncology (ESMO) World Congress on Gastrointestinal Cancer.
- 06 Jul 2015 Results published in Oncolytics Biotech Media Release.
- 29 May 2015 Results of the correlation of outcomes with skeletal muscle changes were presented at the 51st Annual Meeting of the American Society of Clinical Oncology.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History